Mariliv Tablet with Silymarin and Choline Bitartrate

It promotes liver cell regeneration and enhances protein synthesis, contributing to improved liver function in conditions such as hepatitis, cirrhosis, and fatty liver disease. Choline Bitartrate, an essential nutrient, supports lipid metabolism and prevents fat accumulation in the liver, thereby aiding in maintaining cellular integrity and optimal hepatic function. The combination of Silymarin and Choline Bitartrate in Mariliv Tablet offers a synergistic effect, improving detoxification processes and reducing liver enzyme levels elevated due to hepatic injury or dysfunction.

This medication is indicated for patients with liver disorders, including alcoholic and non-alcoholic fatty liver disease, drug-induced liver damage, and chronic liver conditions. Mariliv should be used under medical supervision, with dosage adjusted according to the severity of the condition and patient response. It is generally well-tolerated, with minimal adverse effects reported.